The Galaxy Securities Research Report points out that Midea Group's 2B business has become an important driving force for growth, the organizational structure continues to be segmented, and mergers and acquisitions continue to be integrated. The acquisition of Carestream International will enable Midea Group to acquire Ruike Medical's overseas sales network, radiology technology platform, and overseas R&D team. The market is quite worried about the impact of declining domestic sales of home appliances and rising costs due to rising copper prices, but these have recently been mitigated. As of December 8, 2025, the company has completed a 10 billion yuan share repurchase plan and has repurchased 135 million shares, of which 95 million shares will be cancelled. Considering that the company's expected dividend rate will reach 70%, the combined dividend yield of cancellation+dividends is attractive. The corresponding P/E for the current stock price is 13.1/11.8/10.7 times, maintaining the “recommended” rating.

The Galaxy Securities Research Report points out that Midea Group's 2B business has become an important driving force for growth, the organizational structure continues to be segmented, and mergers and acquisitions continue to be integrated. The acquisition of Carestream International will enable Midea Group to acquire Ruike Medical's overseas sales network, radiology technology platform, and overseas R&D team. The market is quite worried about the impact of declining domestic sales of home appliances and rising costs due to rising copper prices, but these have recently been mitigated. As of December 8, 2025, the company has completed a 10 billion yuan share repurchase plan and has repurchased 135 million shares, of which 95 million shares will be cancelled. Considering that the company's expected dividend rate will reach 70%, the combined dividend yield of cancellation+dividends is attractive. The corresponding P/E for the current stock price is 13.1/11.8/10.7 times, maintaining the “recommended” rating.